Bajaj Finance Share Price Today, October 6: Bajaj Finance Stock Rallies 2.43% in Early Trade After Posting Strong FY26 Q2 AUM Growth; Check Latest Price on NSE

Shares of Bajaj Finance Ltd (NSE: BAJFINANCE) rallied on Monday, October 6, following the company’s strong FY26 Q2 AUM growth, reflecting positive investor sentiment. The stock opened at INR 993.00 against its previous close of INR 989.75, and by 10:23 AM, it was trading at INR 1,013.85, up 2.43% in early trade. The surge comes after Bajaj Finance reported a 24% year-on-year rise in Assets Under Management (AUM), reaching INR 4,62,250 crore in Q2 FY26, compared to INR 3,73,924 crore a year earlier. The stock has a 52-week high of INR 1,036.00 and a 52-week low of INR 645.10, reflecting significant volatility and investor interest.

Bajaj Finance Share Price Today, October 6:

Bajaj Finance Share Price on NSE (Photo Credits: nseindia.com)
TruLY Score by LatestLY
Rating:5

TruLY Score 5 – Trustworthy | On a Trust Scale of 0-5 this article has scored 5 on LatestLY. It is verified through official sources (NSE Website). The information is thoroughly cross-checked and confirmed. You can confidently share this article with your friends and family, knowing it is trustworthy and reliable.

Latest

Is NPS Swasthya enough for medical emergencies? Here’s the reality

With rising healthcare costs, many are turning to NPS Swasthya as a safety net. But is it enough when a real emergency strikes? The answer may not be as reassur

Explained: Why stock markets are rising even as crude oil remains above $100

Benchmark indices rallied in early trade on Monday despite crude oil remaining elevated above $100. The move reflected bargain buying and global AI-led optimism

Sun Pharma’s biggest-ever bet: Why markets cheered the Organon mega deal

Sun Pharma just made the biggest bet in Indian pharma history. Markets loved it instantly. Here’s why investors backed the Organon deal despite the massive pr

Cohance Lifesciences hits 20% upper circuit: Why the stock rising today?

Cohance Lifesciences jumped 20% after appointing former Cipla CEO Umang Vohra. Investors are betting his leadership can accelerate growth and transform the comp

Decoding the Sun Pharma $11.75 billion deal: Why the pharma stock jumped 7% today?

The stock was trading around Rs 1,739.70 as of 9:46 am, up over 7%, after touching a high of Rs 1,741.85 during the session, reflecting strong investor interest

Topics

Need money to study, need education to earn: The vicious loop trapping students

Many students need to borrow money money before they can access quality education, yet need education first to earn money. This creates a cycle of education loa

Which place is known as the Wildlife Capital of the world?

Nairobi is called the wildlife capital of the world for a reason. It is the only city where a national park sits right next to the skyline, blending wild animal

AI era hiring: Rs 50,000 stipend, flexible roles, and real work from day 1

Newton School of Technology's latest placement cycle expanded from 10 roles to 11 as companies assessed candidates in real time. The shift highlighted growing d

Is NPS Swasthya enough for medical emergencies? Here’s the reality

With rising healthcare costs, many are turning to NPS Swasthya as a safety net. But is it enough when a real emergency strikes? The answer may not be as reassur

Cursor AI Agent wipes out startup database in 9 seconds, founder shares 30-hour chaos timeline

A startup founder said Cursor AI Agent erased the company database in nine seconds. The account traced 30 hours of disruption after the incident.

Explained: Why stock markets are rising even as crude oil remains above $100

Benchmark indices rallied in early trade on Monday despite crude oil remaining elevated above $100. The move reflected bargain buying and global AI-led optimism

Reopen the Strait of Hormuz and end the war, Iran offers new proposal to US

Iran has reportedly offered a two-stage plan to US via intermediary Pakistan, which offers prolonged period of ceasefire extension or a permanent end to the war

Sun Pharma’s biggest-ever bet: Why markets cheered the Organon mega deal

Sun Pharma just made the biggest bet in Indian pharma history. Markets loved it instantly. Here’s why investors backed the Organon deal despite the massive pr
spot_img

Related Articles

Popular Categories

spot_imgspot_img